This is why conversations around weight loss are evolving
Patients with T2DM experience a significant decline in the incretins functional properties which causes delayed and reduced insulin release after glucose administration and impairs glucose tolerance [12,13,14]
On May 12, 2023, LaNova Medicines announced the signing of an exclusive licensing agreement with AstraZeneca for LM-305, a pre-clinical stage antibody-drug conjugate comprising an anti-GPRC5D monoclonal antibody, a degradable protease linker, and a cytotoxic payload of MMAE
To control for additional confounders, linear regression models were fit with each AUC as the dependent variable and group as the predictor of interest along with age, AUDIT-C score, body mass index (BMI), and sex